Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia

Published:2018-06-26 Issue:10 Volume:65 Page:e27300
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mogensen Signe Sloth¹^ORCID,Harila-Saari Arja²^ORCID,Mäkitie Outi³⁴,Myrberg Ida Hed²,Niinimäki Riitta⁵⁶^ORCID,Vestli Anne⁷,Hafsteinsdottir Solveig⁸,Griškevicius Laimonas⁹¹⁰,Saks Kadri¹¹,Hallböök Helene¹²,Retpen Jens¹³,Helt Louise Rold¹,Toft Nina¹⁴,Schmiegelow Kjeld¹¹⁵^ORCID,Frandsen Thomas Leth¹^ORCID,

Affiliation:

1. Department of Pediatrics and Adolescent Medicine; the Juliane Marie Center; University Hospital Rigshospitalet; Copenhagen Denmark

2. Childhood Cancer Research Unit; Department of Women's and Children's Health; Karolinska Institutet; Stockholm Sweden

3. Department of Molecular Medicine and Surgery and Center for Molecular Medicine; Karolinska Institutet; Stockholm Sweden

4. Department of Clinical Genetics; Karolinska University Hospital; Stockholm Sweden

5. Department of Children and Adolescents; Oulu University Hospital; Oulu Finland

6. PEDEGO Research Unit; University of Oulu; Oulu Finland

7. Department of Pediatric Oncology and Hematology; Division of Pediatric and Adolescent Medicine; Oslo University Hospital; Oslo Norway

8. Children's Hospital; Landspitali University Hospital; Reykjavik Iceland

9. Department of Hematology; Oncology, and Transfusion Medicine Center; Vilnius University Hospital Santariskiu Klinikos; Vilnius Lithuania

10. Faculty of Medicine; Vilnius University; Vilnius Lithuania

11. Department of Hematology Oncology; Tallinn Children´s Hospital; Tallinn Estonia

12. Department of Medical Sciences; Uppsala University; Uppsala Sweden

13. Department of Orthopedic Surgery; University Hospital Herlev Gentofte; Copenhagen Denmark

14. Department of Hematology; University Hospital Rigshospitalet; Copenhagen Denmark

15. Institute of Clinical Medicine; Faculty of Medicine; University of Copenhagen; Copenhagen Denmark

Funder

Børnecancerfonden

Barncancerfonden

Dagmar Marshalls Fond

Dansk Kraeftforsknings Fond

Ingeniør Otto Christensens Fond

Axel Muusfeldts Fond

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.27300/fullpdf

Reference48 articles.

1. Childhood acute lymphoblastic leukemia: progress through collaboration;Pui;J Clin Oncol,2015

2. Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998-2008;Toft;Br J Haematol,2012

3. Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol;Hallböök;Cancer,2006

4. Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia;DeAngelo;Leukemia,2015

5. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study;Huguet;J Clin Oncol,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population‐based study in Sweden, Finland, and Denmark;Pediatric Blood & Cancer;2024-08-14

2. Radiological follow‐up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma;British Journal of Haematology;2024-08-03

3. Bisphosphonate treatment for skeletal complications in paediatric cancer—Experience from a single tertiary centre;Acta Paediatrica;2024-02-08

4. Chemotherapy‐related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia;Acta Paediatrica;2024-01-04

5. Development of osteonecrosis and improved survival in B-ALL: results of Children’s Oncology Group Trial AALL0232;Leukemia;2023-12-07